# Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia

> **NCT01757769** · PHASE4 · COMPLETED · sponsor: **RECORDATI GROUP** · enrollment: 1036 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia

## Interventions

- **DRUG:** Silodosin

## Key facts

- **NCT ID:** NCT01757769
- **Lead sponsor:** RECORDATI GROUP
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2013-03
- **Final completion:** 2013-08
- **Target enrollment:** 1036 (ACTUAL)
- **Last updated:** 2014-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01757769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01757769, "Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01757769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*